Every newly developed technology with potential for further development into a drug, vaccine, or medical diagnostic should be licensed with a concrete and transparent strategy to make affordable versions available in resource-limited countries for medical care.

. Biopharmaceutical product development is costly and requires infrastructure and efficient resources, making licensing collaborations an attractive option for many global pharmaceutical companies. Licenses are complex, and each one is unique.

. These licensing options help companies recoup research and development investments and bypass the cumbersome innovation and development process.